Brown Advisory Portfolio holdings

Brown Advisory's Q2 2017 Portfolio in Review

As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.

• Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
• Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
• Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
• Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
• Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
• Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
• Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.

Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.